Parallel Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $900K | Sell |
14,348
-1,663
| -10% | -$133K | 0.02% | 514 |
|
|
2025
Q4 | $1.53M | Sell |
16,011
-814
| -5% | -$79.8K | 0.03% | 341 |
|
|
2025
Q3 | $1.64M | Buy |
16,825
+455
| +3% | +$47.1K | 0.03% | 316 |
|
|
2025
Q2 | $1.76M | Buy |
16,370
+911
| +6% | +$92.2K | 0.04% | 300 |
|
|
2025
Q1 | $1.56M | Buy |
15,459
+748
| +5% | +$75.3K | 0.04% | 298 |
|
|
2024
Q4 | $1.31M | Buy |
14,711
+1,453
| +11% | +$128K | 0.03% | 327 |
|
|
2024
Q3 | $1.11M | Buy |
13,258
+1,468
| +12% | +$116K | 0.03% | 363 |
|
|
2024
Q2 | $908K | Buy |
11,790
+1,562
| +15% | +$114K | 0.02% | 385 |
|
|
2024
Q1 | $701K | Buy |
10,228
+519
| +5% | +$33.4K | 0.02% | 429 |
|
|
2023
Q4 | $561K | Sell |
9,709
-335
| -3% | -$17.9K | 0.02% | 454 |
|
|
2023
Q3 | $530K | Buy |
10,044
+442
| +5% | +$23.2K | 0.02% | 440 |
|
|
2023
Q2 | $519K | Buy |
9,602
+456
| +5% | +$23.8K | 0.02% | 454 |
|
|
2023
Q1 | $458K | Buy |
9,146
+1,368
| +18% | +$64.5K | 0.02% | 482 |
|
|
2022
Q4 | $360K | Buy |
7,778
+132
| +2% | +$5.72K | 0.02% | 500 |
|
|
2022
Q3 | $296K | Buy |
7,646
+1,447
| +23% | +$58K | 0.01% | 544 |
|
|
2022
Q2 | $231K | Sell |
6,199
-1,530
| -20% | -$62.3K | 0.01% | 627 |
|
|
2022
Q1 | $345K | Buy |
7,729
+1,028
| +15% | +$44.6K | 0.01% | 538 |
|
|
2021
Q4 | $285K | Sell |
6,701
-818
| -11% | -$34.4K | 0.01% | 613 |
|
|
2021
Q3 | $326K | Buy |
7,519
+1,773
| +31% | +$78.4K | 0.01% | 546 |
|
|
2021
Q2 | $246K | Buy |
5,746
+1,381
| +32% | +$58.1K | 0.01% | 602 |
|
|
2021
Q1 | $169K | Buy |
4,365
+723
| +20% | +$27.4K | 0.01% | 695 |
|
|
2020
Q4 | $131K | Sell |
3,642
-1,459
| -29% | -$52.6K | 0.01% | 723 |
|
|
2020
Q3 | $195K | Sell |
5,101
-112
| -2% | -$4.32K | 0.01% | 575 |
|
|
2020
Q2 | $183K | Buy |
5,213
+3
| +0.1% | +$108 | 0.01% | 569 |
|
|
2020
Q1 | $170K | Sell |
5,210
-222
| -4% | -$8.67K | 0.01% | 503 |
|
|
2019
Q4 | $246K | Buy |
5,432
+1,407
| +35% | +$58.9K | 0.02% | 439 |
|
|
2019
Q3 | $164K | Buy |
4,025
+720
| +22% | +$30.5K | 0.01% | 547 |
|
|
2019
Q2 | $142K | Sell |
3,305
-146
| -4% | -$5.62K | 0.01% | 545 |
|
|
2019
Q1 | $132K | Buy |
3,451
+141
| +4% | +$5.38K | 0.01% | 516 |
|
|
2018
Q4 | $116K | Buy |
3,310
+528
| +19% | +$19.1K | 0.02% | 483 |
|
|
2018
Q3 | $107K | Buy |
2,782
+290
| +12% | +$10.1K | 0.01% | 585 |
|
|
2018
Q2 | $81K | Hold |
2,492
| – | – | 0.01% | 596 |
|
|
2018
Q1 | $68K | Buy |
2,492
+6
| +0.2% | +$163 | 0.01% | 602 |
|
|
2017
Q4 | $62K | Sell |
2,486
-126
| -5% | -$3.48K | 0.01% | 627 |
|
|
2017
Q3 | $74K | Buy |
2,612
+41
| +2% | +$1.13K | 0.01% | 568 |
|
|
2017
Q2 | $68K | Buy |
2,571
+144
| +6% | +$3.82K | 0.01% | 599 |
|
|
2017
Q1 | $64K | Buy |
2,427
+211
| +10% | +$5.13K | 0.01% | 583 |
|
|
2016
Q4 | $48K | Buy |
+2,216
| New | +$48.4K | 0.01% | 593 |
|
Other funds holding BSX
VCM
VPM
Parallel Advisors's BSX Position: Q1 2026 in Review
Parallel Advisors reduced its Boston Scientific (BSX) stake by 10% in Q1 2026, selling an estimated $133K and leaving 14,348 shares worth $900K. The position accounts for 0.02% of the portfolio, ranked #514.
Parallel Advisors first reported a position in BSX in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.76M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Parallel Advisors held 14,348 shares of Boston Scientific worth $900K as of Q1 2026.
- Parallel Advisors sold 1,663 Boston Scientific shares in Q1 2026, an estimated $133K.
- Boston Scientific made up 0.02% of Parallel Advisors's portfolio in Q1 2026, its #514 holding.
- Parallel Advisors first reported a position in Boston Scientific in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Boston Scientific position peaked at $1.76M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.